|
|
Post by harryx1 on Aug 4, 2015 14:54:05 GMT -5
|
|
|
|
Post by mssciguy on Aug 4, 2015 15:11:19 GMT -5
But, it's not a cancer drug. Also, the way he frames it in terms of cost, makes it seem very attractive.
Harry do you know of the recent articles that I posted links to in the wikipedia page thread (which by the way has a huge pushback from the editors, though they accepted an edit I made saying Afrezza is approved). Be very careful with wikipedia, huge egos there.
|
|
|
|
Post by esstan2001 on Aug 4, 2015 15:14:36 GMT -5
I tried to add the following 1st comment below the article but was asked to login to Facebook to post, and I do not have a FB acct. Can someone (with said acct) do me a favor, and copy / paste this in for me (and feel free to improve) THANKS !!! There are real benefits to this drug, Afrezza that have not been covered in this article. The PK profile essentially mimics that of the human pancreas, quelling the excursions in blood glucose levels to about half of what can be obtained by optimally timed and dosed injectable RAA's, and it clears the system fully in about 2 hrs, mitigating the risk of insulin stacking & hypos. Expect to NOT burn out your body's cells once on Afrezza, along with reduced possibility of diabetic nerve pain, eye problems, and the myriad of complications associated with the damage brought on by these glucose excursions. And check social media and diabetes site blogs for (near unanimous) ecstatic users... this will likely become the new paradigm in treatment once additional studies are run that allow proper dosing and are designed to demonstrate superiority, to convince the skeptical, conservative slow to adapt docs. |
|
|
|
Post by sla55 on Aug 4, 2015 15:30:23 GMT -5
I tried to add the following 1st comment below the article but was asked to login to Facebook to post, and I do not have a FB acct. Can someone (with said acct) do me a favor, and copy / paste this in for me (and feel free to improve) THANKS !!! There are real benefits to this drug, Afrezza that have not been covered in this article. The PK profile essentially mimics that of the human pancreas, quelling the excursions in blood glucose levels to about half of what can be obtained by optimally timed and dosed injectable RAA's, and it clears the system fully in about 2 hrs, mitigating the risk of insulin stacking & hypos. Expect to NOT burn out your body's cells once on Afrezza, along with reduced possibility of diabetic nerve pain, eye problems, and the myriad of complications associated with the damage brought on by these glucose excursions. And check social media and diabetes site blogs for (near unanimous) ecstatic users... this will likely become the new paradigm in treatment once additional studies are run that allow proper dosing and are designed to demonstrate superiority, to convince the skeptical, conservative slow to adapt docs. I posted your comment for you. |
|
|
|
Post by esstan2001 on Aug 4, 2015 16:05:03 GMT -5
I tried to add the following 1st comment below the article but was asked to login to Facebook to post, and I do not have a FB acct. Can someone (with said acct) do me a favor, and copy / paste this in for me (and feel free to improve) THANKS !!! There are real benefits to this drug, Afrezza that... dosing and are designed to demonstrate superiority, to convince the skeptical, conservative slow to adapt docs. I posted your comment for you. Thanks much sla :-) |
|
|
|
Post by harryx1 on Aug 5, 2015 8:44:28 GMT -5
But, it's not a cancer drug. Also, the way he frames it in terms of cost, makes it seem very attractive. Harry do you know of the recent articles that I posted links to in the wikipedia page thread (which by the way has a huge pushback from the editors, though they accepted an edit I made saying Afrezza is approved). Be very careful with wikipedia, huge egos there. I've probably come across some of them at some point in time. Not sure if you can use some of the ones I have found previously and posted to this board under the Pulmonary Safety studies: mnkd.proboards.com/thread/1974/afrezza-pulmonary-safety-studiesMaybe using the Lantus/Toujeo page as a template might help as well: en.wikipedia.org/wiki/Insulin_glargineIt would be great to get the PK/PD profile characteristics (with image) on the page too. Nice job by the way. |
|
